MAR vs SYRE · P/E 32, rev $13.72B vs $7.60B cap
Marriott International Inc (MAR) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
Marriott International Inc (MAR) is a lodging company listed on US.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported MAR revenue for 2026-06-30 was $13.72B. Net income was $1.41B. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
MAR currently screens at market cap $76.70B and trailing P/E 31.9. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the MAR and SYRE stock pages for the full models.
Not investment advice.